Search

everythinglearnresearchcommunity

for

Search:↓

Collaboration and innovation are key to developing effective, safe hair loss treatments.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

The combination of certain stem cell secretions and Wnt10b helps regenerate hair follicles effectively.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Pituitary imaging is recommended for hyperprolactinemia due to common pituitary issues.

Saw palmetto extract safely improves hair growth and reduces hair loss.

Environmental pollutants can damage hair health and cause hair loss.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Platelet-rich plasma can help thicken the endometrium and improve pregnancy rates.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.

Female pattern hair loss does not significantly affect sexual dysfunction.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Changes in SHBG levels don't predict diabetes risk reduction.